Late expression factor 3 is one of the six AcMNPV genes essential for DNA replication identified through transient replication assays. LEF-3 is a single stranded DNA binding protein responsible for the transportation of the viral helicase (P143) into the nucleus of the infected cell. In this study, a protein complementation-based assay was adapted to identify the region(s) of LEF-3 that is (are) involved in LEF-3-LEF-3 protein interactions. The full-length LEF-3, or various truncated LEF-3 regions were fused with Venus1 (N- terminus portions of full length Venus, a modified yellow fluorescence protein) or Venus2 (C- terminus). Venus1 and Venus2 fragments generated a functional fluorescent Venus protein when the two fragments were brought together by protein-protein interaction of the fused LEF-3 constructs. Fluorescence generated by coexpression of full-length LEF-3 fusion proteins confirmed that LEF-3 exists as homo-oligomer. Interaction between the full-length and the N- terminal (aa 1-189) or C- terminal regions (aa 190-385), and between the various truncated LEF-3 regions suggested the complexity of LEF-3 oligomeric structure. LEF-3 constructs deleted for NLS function revealed cytoplasmic fluorescence, suggesting that LEF-3-LEF-3 interactions occur in the absence of DNA or nuclear proteins. Because LEF-3 is essential for nuclear transporting the viral helicase (P143), the ability of LEF-3 to interact with another viral protein was investigated. P47, a sub-unit of the viral RNA polymerase was chosen because it is cytoplasmic when expressed on its own. The interaction between LEF-3 and P47 produced complete nuclear localized fluorescent signals. Overall, the results suggest that there are multiple regions of LEF-3 that are capable of closely interacting, and that multiple domains are likely involved in the oligomerization of full-length LEF-3. The interaction of LEF-3 with P47 suggests that P47 may be another LEF-3 cargo protein. / Thesis (Master, Microbiology & Immunology) -- Queen's University, 2011-05-27 15:02:53.983

This thesis describes the expression of three human seven transmembrane receptors: the M2 Muscarinic; H1 Histamine and 5HT2A Serotonin receptors, in the baculovirus/insect cell expression system. Purification trials werre conducted on the M2 Muscarinic and H1 Histamine receptors. Preliminary crystallisation attempts were made with the H1 receptor.

Thèse (M.Sc.)--Université Laval, 2008. / Bibliogr. Publié aussi en version électronique dans la Collection Mémoires et thèses électroniques.

Infections by human schistosomes, in particular Schistosoma mansoni, account for significant morbidity and mortality every year in tropical and sub-tropical areas. The eggs of the parasite induce pathological changes in the infected host; in chronic and heavy infections, these changes may lead to death. A well-designed anti-schistosomal vaccine, alone or in concert with existing control measures such as chemotherapy, may prove to be a safe, inexpensive and effective means of reducing the occurrence of severe disease and death in S. mansoni infection. Previous studies have demonstrated the importance of the syncytial layer containing the apical plasma membrane (APM) of S. mansoni in both the survival of the parasite in the mammalian host and as a potential source of immunogens which may be utilized as vaccine candidates. In this paper we present evidence for the protective capacity of several schistosomal antigen preparations, including a calcium binding protein of the APM, S. mansoni calpain (GenBnnk accession no. M74233). We have constructed and characterized expression of a recombinant baculovirus expressing the large subunit of S. mansoni calpain, Sm-p80. This recombinant Sm-p80 is recognized by IgA, IgM, IgG1, and IgG3 isotype antibodies found in S. mansoni-infected human sera and partially-purified recombinant Sm-p80 provided a 29-39% reduction in worm burden in immunized mice challenged with S. mansoni. Our data indicate that Sm-p80 may be a useful vaccine antigen for the reduction of the morbidity associated with S. mansoni infections of mammalian hosts.

No description available.

Thesis advisor: Abhishek Chatterjee / Directed evolution is a powerful technique to expand chemical space in biological systems. In particular, this method has been used to develop cellular machinery to enable genetic code expansion (GCE), the incorporation of unnatural amino acids (UAAs) into proteins during the translation process. GCE relies on evolving an aminoacyl tRNA synthetase (aaRS) and tRNA pair from a different domain of life to incorporate a UAA into proteins in their new host, as these evolutionarily distant pairs are less likely to be cross-reactive with host pairs. The aaRS and tRNA must meet a number of conditions to be useful for GCE: the pair must be orthogonal (non-cross-reactive) to the host’s native aaRS/tRNA pairs in order to ensure site-specific UAA incorporation; the aaRS must have an active site suited to accept the shape of the UAA; and the tRNA must cooperate with the host ribosome, elongation and release factors, and other translational machinery to efficiently incorporate the UAA into the protein. Numerous aaRS/tRNA pairs have been evolved to allow incorporation of diverse UAAs in bacteria due to the tractable nature of these organisms for directed evolution experiments. While an aaRS evolved in bacteria to charge a novel UAA can be used in eukaryotes, tRNAs cannot be evolved for GCE in bacteria and then used in eukaryotes because they will not have evolved in the presence of the correct translational machinery. It is necessary to evolve tRNAs directly in their host cells. Unfortunately for researchers working on GCE in mammalian cells, it is difficult to perform directed evolution on small gene products in these hosts. Transformation efficiency in mammalian cells is poor, and transient transfection yields heterogeneous DNA distribution to target cells, making selection based on performance of individual library members impossible. Viruses are an ideal DNA delivery vector for mammalian cells, as production of recombinant viruses allows control over library member generation, and viruses can be delivered with exquisite copy number control. The Chatterjee lab recently developed a platform, Virus-Assisted Directed Evolution of tRNAs (VADER), using adeno-associated virus (AAV) to evolve tRNAs for GCE directly in mammalian cells. While VADER is the first directed evolution platform that allows the evolution of small gene products in mammalian cells, its efficiency is limited by its continued reliance on transient transfection to deliver non-library DNA that is necessary for the production of rAAV. To overcome this limitation, baculovirus delivery vectors were developed to boost DNA delivery and AAV capsid production to improve virus production efficiency during selections. VADER allows the evolution of tRNAs to incorporate certain UAAs, but the technique relies on installing a UAA into the AAV capsid, which is sensitive to disruption caused by slight modifications in structure. To expand the scope of VADER to evolve tRNAs for UAAs that cannot be incorporated into the AAV capsid, an alternate selection handle (Assembly Activating Protein, or AAP) was deleted from the genome and provided in trans to incorporate 5-hydroxytryptophan (5HTP). Incorporating the UAA into this flexible protein allows UAA-dependent production of AAV and expands the scope of tRNAs that can be evolved in mammalian cells. / Thesis (PhD) — Boston College, 2021. / Submitted to: Boston College. Graduate School of Arts and Sciences. / Discipline: Chemistry.

Le virus de la variole ovine est omniprésent dans les élevages de petits ruminants dans les pays d’Afrique du Nord et particulièrement en Tunisie malgré les campagnes de vaccination annuelles mises en place par les autorités vétérinaires du pays. L’optimisation de la souche vaccinale utilisée passe par le développement de vaccins dits de nouvelle génération tels que les vaccins sous unitaires utilisant des protéines reconnues pour induire une réponse humorale protectrice chez l’animal immunisé. Ceci pourrait être une alternative aux stratégies de lutte actuelles permettant de limiter la dissémination du virus en Tunisie. Peu de données existent sur les antigènes protecteurs spécifiques des virus du genre Capripoxvirus. Ce travail de thèse a ciblé, par homologie aux protéines du virus de la vaccine, quatre protéines du genre Capripoxvirus appartenant au virus de la dermatose nodulaire contagieuse potentiellement immuno-dominantes nommées LSDV60, LSDV117, LSDV122 etLSDV141 respectivement homologues des protéines L1, A27, A33 et B5. En premier lieu, une analyse structurale in silico a permis d’identifier les domaines essentiels de chaque protéine et de vérifier le taux de conservation de ces protéines parmi différents virus appartenant à la famille des poxvirus. Une analyse structurale approfondie mettant en évidence la structure primaire, secondaire et tertiaire de la protéine A27 a été réalisée. Suite à cette étude structurale, les protéines ont été produites dans deux systèmes d’expression différents ; le système eucaryote et le système baculovirus-cellules d’insectes afin de caractériser leur antigénicité vis-à-vis de sérums provenant d’animaux immunisés ou éprouvés.La reconnaissance des protéines d’intérêt en vecteur d’expression eucaryote n’a pas été concluante. En revanche, le système d’expression BEVS a permis la production de la protéine A27 (L1, A33 et B5 encours) avec succès sous forme soluble qui a été correctement reconnue par des sérums provenant de caprins naïfs challengés. La mise en évidence de formes trimériques et hexamériques confirment sonantigénicité. Une immunodétection des peptides correspondants à la protéine A27 synthétisés surmembranes (PepScan) combinée à une analyse in silico ont permis d'identifier des zones susceptibles de constituer des régions épitopiques reconnues situés majoritairement en partie N terminale de la protéine. / The sheep pox virus is omnipresent in small ruminant farms in North African countries andparticularly in Tunisia despite the annual vaccination campaigns set up by the Tunisian veterinaryauthorities. The optimization of the used vaccine strain involves the development of the so-called newgeneration vaccines such as subunit vaccines and this, using proteins recognized to induce a protectivehumoral response in the immunized animal. This could be considered as an alternative to currentcontrol strategies limiting virus spread in Tunisia. Few data exist on protective antigens specific toviruses in the genus Capripoxvirus. By homology to vaccinia virus proteins, this thesis work hastargeted four proteins in the genus Capripoxvirus belonging to the potentially immuno-dominantcontagious nodular dermatosis virus named LSDV60, LSDV117, LSDV122 and LSDV141respectively homologues of proteins L1, A27, A33 and B5. First, an in silico structural analysis hasallowed to identify the essential domains of each protein and to check the conservation rate of theseproteins among different viruses belonging to the poxvirus family. A thorough structural analysisidentifying the primary, secondary and tertiary structure of the A27 protein was conducted. Followingthis structural study, the proteins were produced in two different expression systems, namely theeukaryotic system and the baculovirus-insect cell system, in order to characterize their antigenicity tosera from immunized or proven animals. The recognition of the proteins of interest in the eukaryoticexpression vector has not been conclusive. On the other hand, the BEVS expression systemsuccessfully allowed the production of the A27 protein (L1, A33 and B5 in progress) in a solubleform, which was correctly recognized by sera from challenged naïve goats. Identifying trimeric andhexameric forms confirms its antigenicity. An immunodetection of the peptides corresponding toprotein A27 synthesized on membranes (PepScan) combined with an in silico analysis led to identifyzones capable of constituting recognized epitopic regions located predominantly in part N-terminal ofthe protein.

L'interférence ARN est un processus biologique permettant la dégradation d'un ARN messager par un ARN double brin de courte taille spécifique de cet ARNm. Elle a un potentiel d'application en thérapie antivirale pour peu que les ARN interférents (ARNi) soient délivrés efficacement in vivo. Dans le genre Morbillivirus, on trouve des pathogènes importants en santé publique et vétérinaire tels que le virus de la rougeole et les virus de la peste des petits ruminants (PPR) et de la peste bovine. Il n'existe aucun traitement contre les infections à morbillivirus. L'objectif de ce travail était d'évaluer la possibilité d'administrer in vivo un ARNi actif contre le virus PPR in vitro. Une formulation basée sur des liposomes complexés avec des ARNi ou un adénovirus non réplicatif exprimant des ARN courts en tête d'épingle (shARN) ont été testés chez des chèvres dans un modèle d'épreuve infectieuse avec une souche virulente de PPR. Les différences observées n'étaient cependant pas significatives au plan statistique. Pour améliorer la délivrance par vecteur viral, nous avons comparé un autre vecteur de type baculovirus qui s'est avéré plus efficace in vitro que l'adénovirus précédent. Par ailleurs, nous avons testés in vitro également deux peptides capables de pénétrer dans les cellules. L'un d'entre eux, le Perfect 6 (PF6) a presque complètement inhibé l'expression du gène de la nucléoprotéine par le virus PPR. En revanche, l'autre (PF14) a été moins efficace mais a relativement mieux résisté à l'inhibition de son activité par la présence de fortes concentrations de sérum dans le milieu. Dans le but d'évaluer in vivo ces nouveaux systèmes de délivrance en s'affranchissant du modèle chèvre lourd et couteux à mettre en œuvre, nous avons initié une stratégie de mise au point d'un modèle non infectieux de suivi dynamique de l'interférence ARN chez la souris par imagerie in vivo. Dans ce travail, nous montrons qu'il est possible de mesurer et de standardiser l'expression d'un gène rapporteur comprenant une séquence du virus PPRV et ensuite de quantifier le niveau de dérégulation de l'expression induit par un ARNi dirigé contre le virus PPR. Après calibration, ce modèle est désormais pour tester différents systèmes de délivrance de siRNA chez la souris / RNA interference (RNAi) is the process of mRNA degradation that is induced by double-stranded RNA in a sequence-specific manner. RNAi has a potential of developing into an effective and specific antiviral therapy if small interfering RNAs (siRNAs) can be efficiently delivered in vivo. Morbillivirus genus includes important pathogens of humans and animals, which include measles virus, peste des petits ruminants virus (PPRV) and rinderpest virus. No treatment exists for morbillivirus diseases. The aim of this work was the in vivo delivery of siRNA against PPRV infection. The delivery of siRNA by a liposome and short hairpin RNA (shRNA) by means of a replication deficient adenovirus was tested in goats which were later challenged with PPRV. However, significant therapeutic effects were not obtained. To find more efficient vectors, the PPRV inhibition efficiency of recombinant replication deficient adenovirus and a baculovirus expressing shRNA against nucleoprotein of PPRV were compared in vitro. The baculoviral vector was found to be more efficient. Similarly, two cell penetrating peptides (CPPs) were also compared and PepFect6 (PF6) could deliver siRNA NPPRV1 effectively in vitro resulting in an almost complete inhibition of N gene expression by PPRV. Another CPP, the PF14 though with lower transfection efficiency in vitro, was found to be relatively serum resistant compared to PF6. A small animal model for PPRV infection does not exist. Due to economic, ethical, and biosecurity issues involved with use of small ruminants, a strategy based on the use of a non-infectious mouse model and a dynamic follow up of siRNA treatment by live imaging was developed. We show in this work that it is possible to measure and standardize the expression of a bioluminescent reporter gene containing a PPRV sequence and thus, to quantify a down-regulation of such gene by siRNA against PPRV. After some calibration, siRNA delivery can now be tested in this mouse model for comparing various delivery vectors in vivo.

Les complexes multi-protéiques jouent un rôle crucial dans les cellules vivantes en catalysant et servant d'intermédiaires entre pratiquement toutes les activités cellulaires essentielles. Cependant, un grand nombre de ces machines se trouvent en très faibles quantités dans les cellules en particulier en ce qui concernent les complexes eucaryotes. Ceci est réfractaire à leur extraction à grande échelle et empêche sévèrement l'élucidation de leur structure et fonction. Dans le but de rendre les complexes multi protéiques accessibles par la voie de production recombinante, le groupe Berger a mis au point un ensemble de systèmes d'expression sur mesure pour la surproduction de complexes multi protéiques dans différents organismes hôtes incluant E. coli, les cellules d'insectes et les cellules de mammifères. Ces systèmes et en particulier le système MultiBac baculovirus/cellules d'insecte ont d'ors et déjà grandement contribués à l'étude de l'assemblage structural et fonctionnel à l'échelle moléculaire et atomique de nombreux complexes multi protéiques importants. Cela inclut en particulier le facteur général humain de transcription TFIID, un complexe de ~1.5 MDa qui constitue le sujet de recherche du laboratoire Berger. Mes contributions dans le développement de la technologie pour la production et dans l'élucidation des complexes TFIID humains sont discutées en détails dans cette thèse. / Multiprotein complexes play a crucial role in living cells by catalyzing and mediating virtually all essential cellular activities. However, many of these essential machines exist in very low endogenous amount in cells, in particular for eukaryotic complexes. This is refractory to large-scale extraction from native source material, severely impeding the elucidation of their structure and function. In order to make multiprotein complexes accessible by means of recombinant production, the Berger laboratory has developed an array of advanced expression systems tailor-made for overproducing multiprotein complexes in various host organisms including E. coli, insect cells and mammalian cells. Those systems, in particular the MultiBac baculovirus/insect cell system have already greatly contributed to studying the structural and functional assemblies of numerous important multiprotein complexes in molecular and atomic detail. Notably, this includes also the human general transcription factor TFIID, a ~1.5 MDa complex, which is the research focus of the Berger laboratory. My contributions to the expression technology development and to the structural elucidation of human TFIID complexes are discussed in details in this thesis.

Made available in DSpace on 2015-03-03T15:02:46Z (GMT). No. of bitstreams: 1 AndreaFA_TESE.pdf: 1420174 bytes, checksum: c5656fd03fcd0a38acd22f419f0567c7 (MD5) Previous issue date: 2010-03-12 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / Societal concerns about environmental sustainability has lead to the development of ecologically-friendly alternatives to chemical insecticides for crop protection. One such alternative is biological pest control. In particular, baculoviruses are well suited as insect biopesticides due to their narrow host specificity and relative ease of propagation. In Brazil, the baculovirus Anticarsia gemmatalis nucleopolyhedrovirus (AgMNPV) is the main biological control agent employed for the soybean pest, Anticarsia gemmatalis. This baculovirus biopesticide is currently produced using caterpillars, but increasing market demand for the product has encouraged the development of an in vitro manufacturing process, which can be scaled up to much higher virus productivities. In this study, three wild-type AgMNPV isolates (AgMNPV-2D, AgMNPV-MP2 and AgMNPV-MP5) and a recombinant form (vAgEGT-LacZ) were characterised in terms of occlusion body (OB) production and infection kinetics, to enable future optimisation of the in vitro production process. These viruses were propagated using a Spodoptera frugiperda (IPLB-SF21) insect cell line grown in shaker-flask batch cultures. Among the virus isolates tested, AgMNPV-MP5 was found to be the best producer, yielding (5.3?0.85)x108 OB/mL after 8 days post infection. The characterisation of vAgEGT-LacZ propagation in suspension cell cultures has not been previously reported in the literature; hence it became the main focus for this thesis. In particular, it was carried out a study on the effect of the multiplicity of infection (MOI) on OB production. Five successive batches were performed getting a final production (8.9?1.42)x1014 occlusion bodies, considering that production is related for a bioreactor with final volume of 10m3. A low MOI associated with a fed-batch process for vAgEGT-LacZ production was found to support a 3-fold higher OB yield when compared to the default batch process (1.8x107 and 5.3x107 OB/mL, respectively). This yield is competitive with regards to the production process. / A preocupa??o da sociedade com o meio ambiente tem levado a buscar alternativas de substitui??o dos inseticidas qu?micos por outros produtos menos agressivos ao homem e ao ambiente. Assim, a utiliza??o de controle biol?gico contra pragas ? altamente desej?vel, pois reduz os riscos ambientais e p?blicos da utiliza??o de produtos qu?micos convencionais. Em particular, os v?rus do tipo baculov?rus s?o uma grande alternativa devido ? especificidade oferecida aos seus hospedeiros e a sua forma de propaga??o. No Brasil, o baculov?rus Anticarsia gemmatalis multiple nucleopolyhedrovirus (AgMNPV) ? o principal agente de controle biol?gico da praga da soja Anticarsia gemmatalis. A crescente demanda deste bioinseticida tem estimulado o interesse no desenvolvimento de processos com base na produ??o in vitro de baculov?rus. Deste modo, poder? aumentar a oferta de v?rus, suprindo a necessidade do mercado deste bioinseticida para o controle de A. gemmatalis. Neste trabalho, estrat?gias de produ??o in vitro do baculov?rus selvagem AgMNPV e do seu recombinante vAgEGT?-LacZ, como influ?ncia do isolado, da cin?tica e do modo de opera??o, foram analisadas como alternativa para futura amplia??o de escala na produ??o deste bioinseticida viral. A produ??o em batelada de tr?s isolados selvagens do baculov?rus AgMNPV (AgMNPV-2D, AgMNPV-MP2 e AgMNPV-MP5) utilizando o cultivo em shaker, foi realizada com a finalidade de selecionar o melhor produtor de corpos de oclus?o a partir das infec??es em c?lulas de inseto Spodoptera frugiperda, linhagem IPLB-SF21 para avalia??o comparativa com recombinante vAgEGT?-LacZ. A sele??o identificou o isolado AgMNPVMP5 como melhor produtor de corpos de oclus?o de (5,30?0,85) x108 OB/mL em 8 dias de infec??o. A produ??o in vitro do vAgEGT?-LacZ foi foco principal deste trabalho, pois n?o h?, na literatura, a produ??o deste recombinante em sistemas de cultivo em suspens?o. Foi realizado estudo da multiplicidade de infec??o para identificar a quantidade de in?culo viral para o cultivo. A partir da?, foram realizadas cinco bateladas sucessivas obtendo-se (8,9?1,42)x1014 corpos de oclus?o para um volume final de 10m? de suspens?o de c?lulas infectadas. O aumento da produ??o de corpos de oclus?o obtidos a partir do vAgEGT?-LacZ foi analisado utilizando a estrat?gia de cultivo em batelada alimentada utilizando baixa multiplicidade de infec??o. Esta estrat?gia permitiu aumento de tr?s vezes na produ??o de corpos de oclus?o quando comparada ? produ??o em cultivos em batelada (5,3x107 e 1,8x107 OB/mL, respectivamente). E ainda, o baculov?rus recombinante vAgEGT?-LacZ mostrou-se competitivo em rela??o ao baculov?rus selvagem AgMNPV-MP5